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Introduction
The pulvinar sign, that is bilateral pulvinar hyperintensity on T2/fluid-attenuated inversion recovery (FLAIR) and diffusion weighted imaging (DWI) magnetic resonance imaging (MRI), is claimed to be a strong indicator, in an appropriate clinical context, of variant Creutzfeldt-Jakob Disease (vCJD), which is related to the United Kingdom bovine spongiform encephalopathy epidemic of 1996. 1 However, it is also described in several other neurological diseases, many of which are treatable (see Discussion). Thus, it is very important for clinicians to consider treatable disorders in the differential diagnosis of this radiological sign. We report the case of a 68-year-old woman with paraneoplastic encephalitis associated with anti-HU antibodies, for which brain MRI showed bilateral posterior thalamic hyperintensities, akin to the pulvinar sign, along with other paraclinical results misleadingly pointing towards a vCJD.
Case report
A 68-year-old Caucasian woman from eastern Canada presented with progressive drowsiness and weight loss over one month without any focal neurological symptoms. She also experienced transient (a few seconds) disturbances of consciousness in which she was found mute, unresponsive and flaccid. Her medical history was unremarkable except for recent smoking cessation. She had never been to Europe. The initial physical and neurological exams were otherwise normal.
Investigation
Brain MRI showed bilateral and asymmetrical T2/ FLAIR, and less markedly, DWI hyperintensities involving the posterior nuclei (pulvinar) of the thalamus, as well as punctiform hyperintense lesions in the parasagittal area. The apparent diffusion coefficient (ADC) sequence was not compatible with diffusion restriction (Figure 1 ). None of these lesions demonstrated post-gadolinium enhancement. A second MRI was performed 22 days later and showed a slight progression of the bithalamic hyperintensities. Cerebrospinal fluid (CSF) analysis showed mild pleocytosis (48 white blood cells, 47 mononuclear) with slightly elevated CSF proteins (0.95 g/L). CSF cytopathology did not show any sign of malignancy. Electroencephalography disclosed diffuse slowing without any epileptiform abnormalities or periodic discharges. Routine haematological and biochemical analyses, as well as serological testing for systemic autoimmune and infectious disorders, were unremarkable except for severe hyponatremia (minimal value at 120 mmol/L). An onconeuronal antibodies panel showed anti-HU positivity (diagnostic methods: immunofluorescence by Immco Reference Laboratory and Western blot by Euroimmun), while other onconeural antibodies (YO, RI, CV2, MA2 and amphiphysine), antibodies against cell surface antigens (NMDAR, LGI1, CASPR2, AMPAR, GLYR and GABA B R) and GAD65 antibodies were all negative. Whole-body computed tomography scan revealed suspect hilar nodules and enlarged lymph nodes in subclavicular regions. A biopsy of these lymph nodes confirmed a metastatic small cell lung carcinoma (SCLC). Considering the pulvinar sign, CSF 14-3-3, hTau and S100 proteins were analysed to rule out vCJD. All these were strongly positive (14-3-3: 48384 Au/ml; hTau: 3589 pg/ml; S100 >4.0 ng 3 ml), with respective specificity for prion diseases reported at 96%, 2 88% and 87%, 3 which theoretically combine for a 99.3% specificity.
Treatment and evolution
Despite the gradual normalisation of natremia over several days, the patient did not improve and presented increasingly frequent episodes of loss of consciousness, initially interpreted as dyscognitive focal seizures and treated with anticonvulsants. She eventually became more and more stuporous to the point of requiring mechanical ventilation. When the results of the biopsy were available, given the demonstration of malignancy and the family and patient's wishes, the patient was placed on palliative care. Final results from the onconeuronal antibodies panel and prion diseases tests were still pending at the time of the decision, but the possibility of a paraneoplastic encephalitis was discussed among the possible diagnoses that would explain her clinical state. In accordance with family wishes, no autopsy was performed. 
Discussion
A diagnosis of anti-HU paraneoplastic encephalitis was established in our patient. HU antibodies positivity has a specificity of 99% for anti-HU neurological syndromes. More than 90% of anti-HU encephalitis is associated with SCLC, which was confirmed by pathology in our patient. Moreover, there was no better alternative diagnosis given the clinical presentation and the patient's history. An anti-HU-related neurological syndrome can be evoked in the presence of 'clinical signs and symptoms of CNS dysfunction and/or sensory neuropathy not caused by metastases or other disorders, and HU antibody-positive serum or CSF'. 4 Clinically, it generally presents with limbic encephalitis (i.e. memory problems, changes in personality, seizures and mood alterations), autonomic neuropathies, sensory neuronopathies and other peripheral neuropathies. 5 This is the first published case of an anti-HU encephalitis with the pulvinar sign. Typically, MRI findings are unremarkable in the majority of patients. Most abnormalities are transient T2-hypersignal areas in the medial temporal region, which probably denote an early inflammatory component. 4 Moreover, prior pathology and autopsy studies do not report the thalamus as a location of anti-HU-associated paraneoplastic encephalomyelitis. 6 Interestingly, there is a published case report of pathological findings predominantly involving the thalamus in a patient with lung cancer and encephalitis, although there were no MRI findings or antibodies analysis reported. 7 Our case report reinforces the notion that the pulvinar sign has to be interpreted cautiously because it may occur with a treatable illness. Indeed, paraneoplastic anti-HU encephalitis is curable with early treatment of the associated cancer. 4 In the present case, unfortunately, the disease (metastatic SCLC) had already progressed too much prior to the investigations, making such treatments of limited value. Other treatable diseases for clinicians to bear in mind when facing the pulvinar sign are benign intracranial pressure, 8 Wernicke's encephalopathy, 9 coeliac disease, 10 paraneoplastic limbic encephalitis associated with non-Hodgkin lymphoma, 11 cat-scratch disease, 12 acute encephalitis, 13 acute disseminated encephalomyelitis (ADEM), 14 post-infectious encephalitis 15 and anti-glutamic acid receptor (anti-GluR) encephalitis. 16 A T1 hyperintense pulvinar sign is also described in Fabry's disease. 17 Vitali et al. 18 showed that restricted diffusion signals are generally not seen in rapidly progressive dementias (RPD), except in the context of prion diseases. Hyperintensities in the FLAIR sequence and, less markedly, in the DWI sequence are, however, common. Our case is consistent with these findings because the ADC sequence did not show a pattern of restricted diffusion, despite the DWI hyperintensities. Most published cases of the pulvinar sign related to vCJD emphasise the DWI and FLAIR sequences, with no reference to ADC. Restricted diffusion, as determined by the ADC sequence, might therefore be a crucial radiological variable in order to differentiate between prion disease-related dementias and other RPDs in the presence of DWI/FLAIR hyperintensities.
Also highlighted within this case study is the caution needed in the interpretation of 14-3-3, hTau and S100 proteins tests. These indexes theoretically combine for a very high specificity (99.3%) for prion disease, but only with a high pre-test probability as determined by the clinical presentation. Their positivity, in addition to the presence of a pulvinar sign, which is the radiological hallmark of vCJD 19 and among the 'probable vCJD' diagnostic criteria from the World Health Organization, 1 could lead to a wrong diagnosis. The patient's history and neurological examination are crucial to put such results into perspective. In this case, the patient had absolutely no risk factor for vCJD, as she had never been to the UK or even to Europe and this disease is related to the UK bovine spongiform encephalopathy epidemic of 1996.
A limitation to the present report is that no postmortem pathology tests were done to exclude without any doubt the co-existence of vCJD and an anti-HU encephalitis, although this possibility is highly unlikely given the very low incidence of both these pathologies.
